Gadopentetate dimeglumine and Necitumumab Intravenous
Determining the interaction of Gadopentetate dimeglumine and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gadopentetate dimeglumine
Brand name: Magnevist, Multihance
Synonyms: Gadopentetate Injection
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gadopentetate dimeglumine-Necon
- Gadopentetate dimeglumine-Necon 0.5/35
- Gadopentetate dimeglumine-Necon 1/35
- Gadopentetate dimeglumine-Necon 1/50
- Gadopentetate dimeglumine-Necon 1/50 (28)
- Gadopentetate dimeglumine-Necon 7/7/7
- Necitumumab Intravenous-Gadopentetate Injection
- Necitumumab Intravenous-Gadopentetate Intravenous
- Necitumumab Intravenous-Gadoterate Intravenous
- Necitumumab Intravenous-Gadoterate meglumine
- Necitumumab Intravenous-Gadoteridol
- Necitumumab Intravenous-Gadoteridol Intravenous